Rogletimide
N/A
Report date: 2022/06/27 17:36:27
NME
Base Information
Drug NameRogletimide
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1957/04/16
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Cancer Research
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsN/A
Inactive Indications